MAXCYTE, INC. Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Maxcyte, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Maxcyte, Inc. Return On Equity for the quarter ending June 30, 2024 was -15.5 %, a 18.6% decline year-over-year.
  • Maxcyte, Inc. annual Return On Equity for 2023 was -15.9 %, a 73.3% decline from 2022.
  • Maxcyte, Inc. annual Return On Equity for 2022 was -9.17 %, a 17.5% increase from 2021.
  • Maxcyte, Inc. annual Return On Equity for 2021 was -11.1 %, a 72.6% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -15.5 -2.43 -18.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -15.7 -3.69 -30.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -15.9 -6.72 -73.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -15.4 -6.23 -68.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -13.1 -5.49 -72.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -12 -4.6 -62.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -9.17 +1.94 +17.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -9.12 +5.62 +38.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -7.6 +22.7 +74.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -7.39 +26.6 +78.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -11.1 +29.5 +72.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -14.7 Jul 1, 2021 Sep 30, 2021
Q2 2021 -30.3 Apr 1, 2021 Jun 30, 2021
Q1 2021 -34 Jan 1, 2021 Mar 31, 2021
Q4 2020 -40.6 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.